UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Is more of a good thing still a good thing? PARP inhibitor retreatment in high-grade ovarian carcinoma

Annals of oncology, 2023-12, Vol.34 (12), p.1074-1076

2023

Volltextzugriff (PDF)

ESMO–ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease

Annals of oncology, 2019-05, Vol.30 (5), p.672-705

2019

Volltextzugriff (PDF)

ESMO-ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease

International journal of gynecological cancer, 2019-05, Vol.29 (4), p.728-760

2019

Volltextzugriff (PDF)

Editorial Expression of Concern: Herpes simplex virus thymidine kinase/ganciclovir–induced cell death is enhanced by co-expression of caspase-3 in ovarian carcinoma cells

Cancer gene therapy, 2024-06, Vol.31 (6), p.955-955

2024

Volltextzugriff (PDF)

A randomised, placebo-controlled trial of weekly paclitaxel and saracatinib (AZD0530) in platinum-resistant ovarian, fallopian tube or primary peritoneal cancer

Annals of oncology, 2014-10, Vol.25 (10), p.1988-1995

2014

Volltextzugriff (PDF)

A randomised, phase II trial of the DNA-hypomethylating agent 5-aza-2′-deoxycytidine (decitabine) in combination with carboplatin vs carboplatin alone in patients with recurrent, partially platinum-sensitive ovarian cancer

British journal of cancer, 2014-04, Vol.110 (8), p.1923-1929

2014

Volltextzugriff (PDF)

Prognostic pathways in early-stage ovarian cancer: can gene expression transcend histological subtype?

Annals of oncology, 2016-08, Vol.27 (8), p.1366-1368

McNeish, I.A.

2016

Volltextzugriff (PDF)

Targeted anti-vascular therapies for ovarian cancer: current evidence

British journal of cancer, 2013-02, Vol.108 (2), p.250-258

2013

Volltextzugriff (PDF)

Fifth Ovarian Cancer Consensus Conference: individualized therapy and patient factors

Annals of oncology, 2017-04, Vol.28 (4), p.702-710

2017

Volltextzugriff (PDF)

Routine germline BRCA1 and BRCA2 testing in patients with ovarian carcinoma: analysis of the Scottish real‐life experience

BJOG : an international journal of obstetrics and gynaecology, 2018-10, Vol.125 (11), p.1451-1458

2018

Volltextzugriff (PDF)

Safe administration of chemotherapy in mast cell activation syndrome

Journal of oncology pharmacy practice, 2021-06, Vol.27 (4), p.1005-1010

2021

Volltextzugriff (PDF)

HRD testing for all advanced high-grade ovarian carcinoma in first line?

ESMO open, 2024-07, Vol.9 (7), p.103627, Article 103627

2024

Volltextzugriff (PDF)

OC04.06: A comparison of the homologous recombination deficiency test success rate using samples from ultrasound‐guided biopsies and those obtained during laparotomies in advanced ovarian cancer

Ultrasound in obstetrics & gynecology, 2024-09, Vol.64 (S1), p.11-12

2024

Volltextzugriff (PDF)

A novel cell line panel reveals non-genetic mediators of platinum resistance and phenotypic diversity in high grade serous ovarian cancer

Gynecologic oncology, 2022-10, Vol.167 (1), p.96-106

2022

Volltextzugriff (PDF)

Oncolytic adenoviral mutants induce a novel mode of programmed cell death in ovarian cancer

Oncogene, 2008-05, Vol.27 (22), p.3081-3090

2008

Volltextzugriff (PDF)

Methanol-based fixation is superior to buffered formalin for next-generation sequencing of DNA from clinical cancer samples

Annals of oncology, 2016-03, Vol.27 (3), p.532-539

2016

Volltextzugriff (PDF)

Low-Risk Persistent Gestational Trophoblastic Disease: Outcome After Initial Treatment With Low-Dose Methotrexate and Folinic Acid From 1992 to 2000

Journal of clinical oncology, 2002-04, Vol.20 (7), p.1838-1844

2002

Volltextzugriff (PDF)

openFrame: A modular, sustainable, open microscopy platform with single-shot, dual-axis optical autofocus module providing high precision and long range of operation

Journal of microscopy (Oxford), 2023-11, Vol.292 (2), p.64-77

2023

Volltextzugriff (PDF)

Low-dose paclitaxel synergizes with oncolytic adenoviruses via mitotic slippage and apoptosis in ovarian cancer

Oncogene, 2010-11, Vol.29 (45), p.6051-6063

2010

Volltextzugriff (PDF)

Response to the letter entitled “Glomerular filtration rate estimation for carboplatin dosing in patients with gynaecological cancers”

ESMO open, 2022-08, Vol.7 (4), p.100534, Article 100534

2022

Volltextzugriff (PDF)

Gene Therapy Progress and Prospects: cancer gene therapy using tumour suppressor genes

Gene therapy, 2004-03, Vol.11 (6), p.497-503

2004

Volltextzugriff (PDF)

Safety and utility of image-guided research biopsies in relapsed high-grade serous ovarian carcinoma—experience of the BriTROC consortium

British journal of cancer, 2017-05, Vol.116 (10), p.1294-1301

2017

Volltextzugriff (PDF)

2770 Routine germline BRCA testing in serous ovarian cancer: The West of Scotland experience

European journal of cancer (1990), 2015-09, Vol.51, p.S554-S554

2015

Volltextzugriff (PDF)

Are rigid management protocols stifling innovation in cancer treatment?

BJOG : an international journal of obstetrics and gynaecology, 2015-10, Vol.122 (11), p.1432-1434

2015

Volltextzugriff (PDF)

Lister strain vaccinia virus with thymidine kinase gene deletion is a tractable platform for development of a new generation of oncolytic virus

Gene therapy, 2015-06, Vol.22 (6), p.476-484

2015

Volltextzugriff (PDF)

1 – 25 von 1.234

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(908)
Mit Volltextzugriff
(1.025)

Publikationsform

6 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(1.234)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Annals Of Oncology
(49)
Herald
(38)
The Lancet
(36)
Cancer Research
(33)
International Journal Of Gynecological Cancer
(33)
Archives Of Disease In Childhood
(32)
Journal Of Clinical Oncology
(30)
Clinical Cancer Research
(28)
Pediatric Research
(19)
Gynecologic Oncology
(17)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(8)

Menü

Weitere Dienste

Einstellungen

Is more of a good thing still a good thing? PARP inhibitor retreatment in high-grade ovarian carcinoma

ESMO–ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease

ESMO-ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease

Editorial Expression of Concern: Herpes simplex virus thymidine kinase/ganciclovir–induced cell death is enhanced by co-expression of caspase-3 in ovarian carcinoma cells

A randomised, placebo-controlled trial of weekly paclitaxel and saracatinib (AZD0530) in platinum-resistant ovarian, fallopian tube or primary peritoneal cancer

A randomised, phase II trial of the DNA-hypomethylating agent 5-aza-2′-deoxycytidine (decitabine) in combination with carboplatin vs carboplatin alone in patients with recurrent, partially platinum-sensitive ovarian cancer

Prognostic pathways in early-stage ovarian cancer: can gene expression transcend histological subtype?

Targeted anti-vascular therapies for ovarian cancer: current evidence

Fifth Ovarian Cancer Consensus Conference: individualized therapy and patient factors

Routine germline BRCA1 and BRCA2 testing in patients with ovarian carcinoma: analysis of the Scottish real‐life experience

Safe administration of chemotherapy in mast cell activation syndrome

HRD testing for all advanced high-grade ovarian carcinoma in first line?

OC04.06: A comparison of the homologous recombination deficiency test success rate using samples from ultrasound‐guided biopsies and those obtained during laparotomies in advanced ovarian cancer

A novel cell line panel reveals non-genetic mediators of platinum resistance and phenotypic diversity in high grade serous ovarian cancer

Oncolytic adenoviral mutants induce a novel mode of programmed cell death in ovarian cancer

Methanol-based fixation is superior to buffered formalin for next-generation sequencing of DNA from clinical cancer samples

Low-Risk Persistent Gestational Trophoblastic Disease: Outcome After Initial Treatment With Low-Dose Methotrexate and Folinic Acid From 1992 to 2000

openFrame: A modular, sustainable, open microscopy platform with single-shot, dual-axis optical autofocus module providing high precision and long range of operation

Low-dose paclitaxel synergizes with oncolytic adenoviruses via mitotic slippage and apoptosis in ovarian cancer

Response to the letter entitled “Glomerular filtration rate estimation for carboplatin dosing in patients with gynaecological cancers”

Gene Therapy Progress and Prospects: cancer gene therapy using tumour suppressor genes

Safety and utility of image-guided research biopsies in relapsed high-grade serous ovarian carcinoma—experience of the BriTROC consortium

2770 Routine germline BRCA testing in serous ovarian cancer: The West of Scotland experience

Are rigid management protocols stifling innovation in cancer treatment?

Lister strain vaccinia virus with thymidine kinase gene deletion is a tractable platform for development of a new generation of oncolytic virus

Suchergebnisse filtern